{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:15:47Z","timestamp":1793740547095,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fresenius Medical Care Deutschland GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04494-5","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:13:34Z","timestamp":1760354014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of low serum and dialysate magnesium levels on clinical outcomes in peritoneal dialysis patients: a literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Barbara","family":"Marzell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Tschulena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio Manuel","family":"Jimenez Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kircelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"4494_CR1","doi-asserted-by":"crossref","unstructured":"Aal-Hamad AH, Al-Alawi AM, Kashoub MS, Falhammar H. Hypermagnesemia in clinical practice. Med (Kaunas). 2023;59(7).","DOI":"10.3390\/medicina59071190"},{"issue":"2","key":"4494_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/089686089401400229","volume":"14","author":"T Weinreich","year":"1994","unstructured":"Weinreich T, Huynh U, Zitta S, Binder D, Gantenbein H, Binswanger U. Peritoneal dialysate magnesium\u2013how low is safe? Perit Dial Int. 1994;14(2):195\u20136.","journal-title":"Perit Dial Int"},{"issue":"1","key":"4494_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00012.2014","volume":"95","author":"JH de Baaij","year":"2015","unstructured":"de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1\u201346.","journal-title":"Physiol Rev"},{"issue":"4","key":"4494_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/07315724.1986.10720143","volume":"5","author":"FW Lowenstein","year":"1986","unstructured":"Lowenstein FW, Stanton MF. Serum magnesium levels in the united States, 1971\u20131974. J Am Coll Nutr. 1986;5(4):399\u2013414.","journal-title":"J Am Coll Nutr"},{"issue":"5","key":"4494_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10157-022-02182-4","volume":"26","author":"Y Sakaguchi","year":"2022","unstructured":"Sakaguchi Y. The emerging role of magnesium in CKD. Clin Exp Nephrol. 2022;26(5):379\u201384.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"4494_CR6","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.3390\/nu7095388","volume":"7","author":"U Grober","year":"2015","unstructured":"Grober U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199\u2013226.","journal-title":"Nutrients"},{"issue":"1","key":"4494_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1525-139X.2008.00530.x","volume":"22","author":"JF Navarro-Gonz\u00e1lez","year":"2009","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Garc\u00eda-P\u00e9rez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial. 2009;22(1):37\u201344.","journal-title":"Semin Dial"},{"issue":"1","key":"4494_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41100-017-0142-7","volume":"4","author":"R Ikee","year":"2018","unstructured":"Ikee R. Cardiovascular disease, mortality, and magnesium in chronic kidney disease: growing interest in magnesium-related interventions. Ren Replace Therapy. 2018;4(1):1.","journal-title":"Ren Replace Therapy"},{"issue":"3","key":"4494_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1053\/j.ajkd.2015.01.029","volume":"66","author":"M Alhosaini","year":"2015","unstructured":"Alhosaini M, Leehey DJ. Magnesium and dialysis: the neglected cation. Am J Kidney Dis. 2015;66(3):523\u201331.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"4494_CR10","doi-asserted-by":"publisher","first-page":"i39","DOI":"10.1093\/ndtplus\/sfr166","volume":"5","author":"J Cunningham","year":"2012","unstructured":"Cunningham J, Rodr\u00edguez M, Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):i39\u201351.","journal-title":"Clin Kidney J"},{"key":"4494_CR11","doi-asserted-by":"crossref","unstructured":"Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Magnesium-A more important role in CKD-MBD than we thought. Diagnostics (Basel). 2022;12(4).","DOI":"10.3390\/diagnostics12040880"},{"issue":"7","key":"4494_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ndt\/gfy119","volume":"34","author":"T Oka","year":"2019","unstructured":"Oka T, Hamano T, Sakaguchi Y, Yamaguchi S, Kubota K, Senda M, et al. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease. Nephrol Dial Transpl. 2019;34(7):1154\u201362.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"4494_CR13","first-page":"M801","volume":"39","author":"MS Markell","year":"1993","unstructured":"Markell MS, Altura BT, Sarn Y, Delano BG, Ifudu O, Friedman EA, et al. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis. Asaio J. 1993;39(3):M801\u20134.","journal-title":"Asaio J"},{"issue":"2","key":"4494_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2215\/CJN.07930717","volume":"13","author":"Y Sakaguchi","year":"2018","unstructured":"Sakaguchi Y, Hamano T, Kubota K, Oka T, Yamaguchi S, Matsumoto A, et al. Anion gap as a determinant of ionized fraction of divalent cations in hemodialysis patients. Clin J Am Soc Nephrol. 2018;13(2):274\u201381.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4494_CR15","doi-asserted-by":"publisher","first-page":"sfae046","DOI":"10.1093\/ckj\/sfae046","volume":"17","author":"M Pluquet","year":"2024","unstructured":"Pluquet M, Kamel S, Alencar de Pinho N, Mansencal N, Combe C, Metzger M, et al. Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes. Clin Kidney J. 2024;17(4):sfae046.","journal-title":"Clin Kidney J"},{"key":"4494_CR16","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/PRBM.S476203","volume":"17","author":"YP Cao","year":"2024","unstructured":"Cao YP, Yuan B, Zhang RQ, Ding YM, Shi WJ, Chen RJ, et al. Association between serum magnesium levels and depression in patients undergoing peritoneal dialysis: a study conducted at handan first hospital, China. Psychol Res Behav Manag. 2024;17:3813\u201326.","journal-title":"Psychol Res Behav Manag"},{"issue":"4","key":"4494_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/ki.2015.165","volume":"88","author":"Y Sakaguchi","year":"2015","unstructured":"Sakaguchi Y, Iwatani H, Hamano T, Tomida K, Kawabata H, Kusunoki Y, et al. Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease. Kidney Int. 2015;88(4):833\u201342.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"4494_CR18","doi-asserted-by":"publisher","first-page":"i52","DOI":"10.1093\/ndtplus\/sfr167","volume":"5","author":"ZA Massy","year":"2012","unstructured":"Massy ZA, Dr\u00fceke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J. 2012;5(Suppl 1):i52\u201361.","journal-title":"Clin Kidney J"},{"issue":"9","key":"4494_CR19","doi-asserted-by":"publisher","first-page":"e0163673","DOI":"10.1371\/journal.pone.0163673","volume":"11","author":"Y Sakaguchi","year":"2016","unstructured":"Sakaguchi Y, Hamano T, Nakano C, Obi Y, Matsui I, Kusunoki Y, et al. Association between density of coronary artery calcification and serum magnesium levels among patients with chronic kidney disease. PLoS ONE. 2016;11(9):e0163673.","journal-title":"PLoS ONE"},{"key":"4494_CR20","unstructured":"United States Renal Data System USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2024."},{"key":"4494_CR21","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.ijchy.2019.100005","volume":"1","author":"SG Chrysant","year":"2019","unstructured":"Chrysant SG, Chrysant GS. Association of hypomagnesemia with cardiovascular diseases and hypertension. Int J Cardiol Hypertens. 2019;1:100005.","journal-title":"Int J Cardiol Hypertens"},{"key":"4494_CR22","doi-asserted-by":"publisher","first-page":"e14203","DOI":"10.7717\/peerj.14203","volume":"10","author":"CY Huang","year":"2022","unstructured":"Huang CY, Yang CC, Hung KC, Jiang MY, Huang YT, Hwang JC, et al. Association between hypomagnesemia and mortality among dialysis patients: a systematic review and meta-analysis. PeerJ. 2022;10:e14203.","journal-title":"PeerJ"},{"issue":"3","key":"4494_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1681\/ASN.2017080849","volume":"29","author":"Y Sakaguchi","year":"2018","unstructured":"Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I. Magnesium and risk of hip fracture among patients undergoing hemodialysis. J Am Soc Nephrol. 2018;29(3):991\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"4494_CR24","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1681\/ASN.2007070792","volume":"18","author":"CL Huang","year":"2007","unstructured":"Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"4494_CR25","doi-asserted-by":"publisher","first-page":"1875358","DOI":"10.1155\/2019\/1875358","volume":"2019","author":"A Hamad","year":"2019","unstructured":"Hamad A, Hussain ME, Elsanousi S, Ahmed H, Navalta L, Lonappan V, et al. Prevalence and management of hypokalemia in peritoneal dialysis patients in Qatar. Int J Nephrol. 2019;2019:1875358.","journal-title":"Int J Nephrol"},{"issue":"1","key":"4494_CR26","first-page":"1","volume":"47","author":"G Li","year":"2019","unstructured":"Li G, Zhang L, Ren H, Huang B, Mao C, Zhou A. Clearance of magnesium in peritoneal dialysis patients: a single-center study. Blood Purif. 2019;47(1):1\u20137.","journal-title":"Blood Purif"},{"issue":"4","key":"4494_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5414\/CN110115","volume":"94","author":"C Holzmann-Littig","year":"2020","unstructured":"Holzmann-Littig C, McCallum W, Heemann U, Renders L, Bietenbeck A, Steubl D. Peritoneal magnesium elimination and its clinical relevance in peritoneal Dialysis patients. Clin Nephrol. 2020;94(4):181\u20136.","journal-title":"Clin Nephrol"},{"issue":"3","key":"4494_CR28","doi-asserted-by":"publisher","first-page":"e0152488","DOI":"10.1371\/journal.pone.0152488","volume":"11","author":"K Cai","year":"2016","unstructured":"Cai K, Luo Q, Dai Z, Zhu B, Fei J, Xue C, et al. Hypomagnesemia is associated with increased mortality among peritoneal Dialysis patients. PLoS ONE. 2016;11(3):e0152488.","journal-title":"PLoS ONE"},{"key":"4494_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IJNRD.S357130","volume":"15","author":"S Kaneko","year":"2022","unstructured":"Kaneko S, Ookawara S, Morishita Y. Clinical factors associated with serum magnesium concentration in patients undergoing peritoneal dialysis: A Single-Center observational study. Int J Nephrol Renovasc Dis. 2022;15:185\u201395.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"6","key":"4494_CR30","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1007\/s12011-022-03391-4","volume":"201","author":"N Su","year":"2023","unstructured":"Su N, Tang X, Wang X, Wen Y, Feng X, Zhou Q, et al. Association of serum magnesium with Gastrointestinal bleeding in peritoneal Dialysis patients: a multicentre retrospective study. Biol Trace Elem Res. 2023;201(6):2775\u201383.","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"4494_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.ajkd.2016.03.428","volume":"68","author":"X Yang","year":"2016","unstructured":"Yang X, Soohoo M, Streja E, Rivara MB, Obi Y, Adams SV, et al. Serum magnesium levels and hospitalization and mortality in incident peritoneal dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(4):619\u201327.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4494_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000514148","volume":"51","author":"F Zhang","year":"2022","unstructured":"Zhang F, Wu X, Wen Y, Zhan X, Peng FF, Wang X, et al. Hypomagnesemia is a risk factor for cardiovascular disease- and noncardiovascular disease-related mortality in peritoneal dialysis patients. Blood Purif. 2022;51(1):23\u201330.","journal-title":"Blood Purif"},{"key":"4494_CR33","first-page":"90","volume":"30","author":"P Fein","year":"2014","unstructured":"Fein P, Weiss S, Ramos F, Singh P, Chattopadhyay J, Avram MM. Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients. Adv Perit Dial. 2014;30:90\u20133.","journal-title":"Adv Perit Dial"},{"issue":"1","key":"4494_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12882-017-0549-y","volume":"18","author":"AO Molnar","year":"2017","unstructured":"Molnar AO, Biyani M, Hammond I, Harmon JP, Lavoie S, McCormick B, et al. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study. BMC Nephrol. 2017;18(1):129.","journal-title":"BMC Nephrol"},{"issue":"3","key":"4494_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0009-9120(96)84729-B","volume":"29","author":"HJ Huijgen","year":"1996","unstructured":"Huijgen HJ, van Ingen HE, Kok WT, Sanders GT. Magnesium fractions in serum of healthy individuals and CAPD patients, measured by an ion-selective electrode and ultrafiltration. Clin Biochem. 1996;29(3):261\u20136.","journal-title":"Clin Biochem"},{"issue":"4","key":"4494_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/089686089701700409","volume":"17","author":"HH Saha","year":"1997","unstructured":"Saha HH, Harmoinen AP, Pasternack AI. Measurement of serum ionized magnesium in CAPD patients. Perit Dial Int. 1997;17(4):347\u201352.","journal-title":"Perit Dial Int"},{"issue":"1","key":"4494_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/089686089501500112","volume":"15","author":"AA Ejaz","year":"1995","unstructured":"Ejaz AA, McShane AP, Gandhi VC, Leehey DJ, Ing TS. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int. 1995;15(1):61\u20134.","journal-title":"Perit Dial Int"},{"issue":"4","key":"4494_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3747\/pdi.2012.00164","volume":"33","author":"H Ye","year":"2013","unstructured":"Ye H, Zhang X, Guo Q, Huang N, Mao H, Yu X, et al. Prevalence and factors associated with hypomagnesemia in Southern Chinese continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2013;33(4):450\u20134.","journal-title":"Perit Dial Int"},{"issue":"1\u20133","key":"4494_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000485315","volume":"45","author":"S Tsai","year":"2018","unstructured":"Tsai S, Zhao H, Wu B, Zuo L, Wang M. Serum magnesium abnormality and influencing factors of serum magnesium level in peritoneal dialysis patients: a single-center study in Northern China. Blood Purif. 2018;45(1\u20133):110\u20137.","journal-title":"Blood Purif"},{"issue":"3","key":"4494_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000186773","volume":"60","author":"T Yamamoto","year":"1992","unstructured":"Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, et al. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron. 1992;60(3):324\u20139.","journal-title":"Nephron"},{"issue":"1","key":"4494_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/089686089401400115","volume":"14","author":"S Takahashi","year":"1994","unstructured":"Takahashi S, Okada K, Yanai M. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1994;14(1):75\u20138.","journal-title":"Perit Dial Int"},{"issue":"2","key":"4494_CR42","first-page":"258","volume":"10","author":"JE Tattersall","year":"1995","unstructured":"Tattersall JE, Dick C, Doyle S, Greenwood RN, Farrington K. Alkalosis and hypomagnesaemia: unwanted effects of a low-calcium CAPD solution. Nephrol Dial Transpl. 1995;10(2):258\u201362.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4494_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000188806","volume":"72","author":"AJ Hutchison","year":"1996","unstructured":"Hutchison AJ, Were AJ, Boulton HF, Mawer EB, Laing I, Gokal R. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations. Nephron. 1996;72(1):52\u20138.","journal-title":"Nephron"},{"issue":"6","key":"4494_CR44","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1177\/089686080502500619","volume":"25","author":"K Eisenman","year":"2005","unstructured":"Eisenman K, Holley JL. A higher magnesium dialysate concentration treats hypomagnesemia. Perit Dial Int. 2005;25(6):604\u20135.","journal-title":"Perit Dial Int"},{"issue":"2","key":"4494_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3904\/kjim.2002.17.2.114","volume":"17","author":"MS Cho","year":"2002","unstructured":"Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002;17(2):114\u201321.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"4494_CR46","first-page":"41","volume":"12","author":"AH Mitwalli","year":"2017","unstructured":"Mitwalli AH. Why are serum magnesium levels lower in Saudi dialysis patients? J Taibah Univ Med Sci. 2017;12(1):41\u20136.","journal-title":"J Taibah Univ Med Sci"},{"issue":"2","key":"4494_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11255-006-0082-6","volume":"38","author":"M Wei","year":"2006","unstructured":"Wei M, Esbaei K, Bargman JM, Oreopoulos DG. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? Int Urol Nephrol. 2006;38(2):317\u201322.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"4494_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/089686080902900511","volume":"29","author":"H Eddington","year":"2009","unstructured":"Eddington H, Hurst H, Ramli MT, Speake M, Hutchison AJ. Calcium and magnesium flux in automated peritoneal dialysis. Perit Dial Int. 2009;29(5):536\u201341.","journal-title":"Perit Dial Int"},{"issue":"2","key":"4494_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/089686080202200217","volume":"22","author":"B Agroyannis","year":"2002","unstructured":"Agroyannis B, Fourtounas C, Kopelias I, Paraskevopoulos A, Bougatsos G, Katsoudas S, et al. Changes in erythrocyte Ca2+, K+, and Mg2\u2009+\u2009content in uremic patients on CAPD. Perit Dial Int. 2002;22(2):269\u201372.","journal-title":"Perit Dial Int"},{"issue":"9","key":"4494_CR50","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1525-1594.2003.07193.x","volume":"27","author":"KP Katopodis","year":"2003","unstructured":"Katopodis KP, Koliousi EL, Andrikos EK, Pappas MV, Elisaf MS, Siamopoulos KC. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs. 2003;27(9):853\u20137.","journal-title":"Artif Organs"},{"issue":"3","key":"4494_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/089686089301300311","volume":"13","author":"AJ Hutchison","year":"1993","unstructured":"Hutchison AJ, Merchant M, Boulton HF, Hinchcliffe R, Gokal R. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol\/L calcium, 0.25 mmol\/L magnesium dialysis fluid. Perit Dial Int. 1993;13(3):219\u201323.","journal-title":"Perit Dial Int"},{"key":"4494_CR52","first-page":"365","volume":"8","author":"MR Merchant","year":"1992","unstructured":"Merchant MR, Hutchinson AJ, Butler SJ, Boulton H, Hintchliffe R, Gokal R. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium\/magnesium and high lactate dialysis fluid. Adv Perit Dial. 1992;8:365\u20138.","journal-title":"Adv Perit Dial"},{"issue":"5","key":"4494_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/089686089901900509","volume":"19","author":"JF Navarro","year":"1999","unstructured":"Navarro JF, Mora C, Macia M, Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int. 1999;19(5):455\u201361.","journal-title":"Perit Dial Int"},{"issue":"1","key":"4494_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/089686089801800111","volume":"18","author":"JF Navarro","year":"1998","unstructured":"Navarro JF, Mora C, Garc\u00eda J, Mac\u00eda M, Gallego E, Chahin J, et al. Hypermagnesemia in CAPD. Relationship with parathyroid hormone levels. Perit Dial Int. 1998;18(1):77\u201380.","journal-title":"Perit Dial Int"},{"issue":"5","key":"4494_CR55","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s11255-022-03445-5","volume":"55","author":"N Shamspour","year":"2023","unstructured":"Shamspour N, Molahoseini M, Azmandian J, Ahmadipour H, Baniasad A. To evaluate the relationship between serum magnesium and parathyroid hormone levels in peritoneal dialysis and hemodialysis patients. Int Urol Nephrol. 2023;55(5):1321\u20137.","journal-title":"Int Urol Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04494-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:13:40Z","timestamp":1760357620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04494-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4494"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04494-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FK, OMJM and UT are employees of Fresenius Medical Care Deutschland GmbH. BM provided medical writing services on behalf of Fresenius Medical Care Deutschland GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}